Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00382_DB00502_nanopub.RAY2RFZIGL5i6WMpROrDxHEv12NO6ib0mpU08kUoW1RqE#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00382_DB00502 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00382_DB00502 label "DDI between Tacrine and Haloperidol - The therapeutic effects of the central acetylcholinesterase inhibitor (AChEI), Tacrine, and/or the anticholinergic/antipsychotic, Haloperidol, may be reduced due to antagonism. This interaction may be beneficial when the anticholinergic action is a side effect. AChEIs may also augment the central neurotoxic effect of antipsychotics. Monitor for extrapyramidal symptoms and decreased efficacy of both agents. [drugbank_resource:DB00382_DB00502]" assertion.
- drugbank_resource:DB00382_DB00502 identifier "drugbank_resource:DB00382_DB00502" assertion.
- drugbank_resource:DB00382_DB00502 title "DDI between Tacrine and Haloperidol - The therapeutic effects of the central acetylcholinesterase inhibitor (AChEI), Tacrine, and/or the anticholinergic/antipsychotic, Haloperidol, may be reduced due to antagonism. This interaction may be beneficial when the anticholinergic action is a side effect. AChEIs may also augment the central neurotoxic effect of antipsychotics. Monitor for extrapyramidal symptoms and decreased efficacy of both agents." assertion.
- drugbank:DB00502 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00382_DB00502 assertion.
- drugbank:DB00382 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00382_DB00502 assertion.